STOCKS TELEGRAPH

Tag: CDLX Stock

  • Cardlytics Inc. (CDLX) Rockets in Afterhours on Positive Earnings Report

    In a whirlwind day, Cardlytics, Inc. (NASDAQ: CDLX) experienced a tumultuous descent of nearly 5% on Thursday, only to witness a dramatic turnaround during afterhours trading, with the market responding exuberantly to the company’s earnings report, propelling the stock price upwards by an astounding 38%.

    Financial Triumphs Amidst Challenges

    The surge followed the unveiling of Cardlytics’ fourth-quarter and full-year financial results for 2023. Renowned for its advertising platform nestled within financial institutions’ digital channels, the company showcased an exemplary performance.

    Total revenue for the fourth quarter soared to $89.2 million, marking an 8.1% surge year-over-year. Impressively, Adjusted EBITDA showcased a significant upswing, reaching $10.0 million, a substantial leap from the negative $6.1 million reported in the fourth quarter of 2022.

    Despite these commendable strides, Cardlytics reported a net loss of $(100.8) million for Q4 2023, albeit a noteworthy improvement from the $(378.3) million loss in the preceding year’s quarter. The company’s billings for Q4 2023 witnessed a robust 4.6% growth to $131.9 million compared to the same period in 2022.

    Furthermore, monthly active users (MAUs) surged to 168.0 million, showcasing a commendable 7.1% increase year-over-year.

    Navigating Challenges and Future Prospects

    Operating primarily through three segments: Cardlytics Direct U.S. and U.K., along with the Bridg platform, Cardlytics is not without its challenges.

    Despite financial triumphs, there remains the pressing need to sustain growth momentum and manage net losses. The company’s performance is meticulously scrutinized, reflecting its ability to thrive in a competitive advertising market and execute effective cost-restructuring initiatives.

    CEO Karim Temsamani expressed unwavering optimism about Cardlytics’ future, underscoring the focus on building a top-tier platform. Meanwhile, CFO Alexis DeSieno reiterated the company’s commitment to achieving growth and enhancing its capital structure.

    Insider Selling Raises Eyebrows

    An intriguing development worth noting is the ongoing trend of insider selling within Cardlytics since 2023, involving key figures including the CEO, COO, and a significant owner. This trend, conspicuously absent of any insider buying, warrants careful attention from investors and stakeholders.

    Conclusion

    As Cardlytics strides into 2024, its resilience and strategic initiatives position it optimistically for continued growth and financial stability. The company’s performance will be keenly observed, signaling significant implications for stakeholders and the broader market. Investors and analysts alike eagerly await further developments, poised to gauge Cardlytics’ trajectory amidst a dynamic economic landscape.

  • Cardlytics (CDLX) Stock: Bullish For Settling A Legal Battle

    Cardlytics (CDLX) Stock: Bullish For Settling A Legal Battle

    Cardlytics, Inc. (NASDAQ: CDLX) is presently undergoing a significant uptick in its stock valuation on US charts. That is showcasing a remarkable 25.56% surge in Cardlytics stock, reaching $7.24 as of the last check during the current trading session. This upward trend follows the successful resolution of a legal conflict, contributing to the favorable momentum in CDLX stock performance.

    In a recent update, Cardlytics (CDLX) officially declared the finalization of a settlement pact with Shareholder Representative Services LLC (SRS). All outstanding issues resulting from the Bridg merger agreement and the related earnout payments between the parties involved are essentially resolved by this agreement.

    Additionally, Cardlytics has made public its preliminary financial results for the fourth quarter concluded on December 31, 2023. Based on preliminary data, the firm appears to have a bright future, with positive adjusted EBITDA predicted for the whole 2023 fiscal year.

    As a result, Cardlytics will be able to comply with the provisions of the credit facility agreement and extend the credit facility’s maturity date to April 2025. On January 25, 2024, Cardlytics finalized a settlement agreement with SRS, the representative entity for former Bridg shareholders.

    The agreement comprehensively resolves disputes linked to the Bridg merger, including those related to the first and second anniversary earnout payments. As part of the settlement terms, Cardlytics committed to a $25 million cash payment to SRS and the issuance of 3.6 million shares of Cardlytics common stock.

    The cash payment structure involves $20 million in January 2024, $3 million in January 2025, and $2 million in June 2025. The issuance of Cardlytics stock is scheduled for February 2024. Notably, Cardlytics is relieved from making any additional payments concerning the previous withholding related to the first-anniversary earnout payment.

    In addition to the settlement details, Cardlytics released preliminary and unaudited financial results for the fourth quarter ending December 31, 2023. CDLX confidently expects to meet or exceed its earlier guidance. The company’s commitment to cost discipline and operational efficiency has proven fruitful, as evidenced by its sustained profitability demonstrated in the fourth-quarter performance.